Kissei Pharmaceutical
Japan - Matsumoto CityPharmaceutical
Focus: Kissei Pharmaceutical is a Japan-based specialty pharma company focused on small molecules, biosimilars, and monoclonal antibodies across women's health, ophthalmology, nephrology, neurology, and metabolic diseases. The company maintains a diversified pipeline with active development across multiple therapeutic areas.
Profile data last refreshed 1h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Kissei Pharmaceutical
AI assessmentNot HiringNo open roles listed right now. Follow Kissei Pharmaceutical to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
17 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
fostamatinib
Chronic Idiopathic Thrombocytopenic PurpuraClinical Trials (1)
NCT06757257Special Drug Use-results Survey for Long-term Use (Fostamatinib)
N/AHelp build intelligence for Kissei Pharmaceutical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.